A Phase II Study of Nivolumab in Combination With Cabozantinib for Metastatic Triple-negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Dana-Farber Cancer Institute
Related studies linked through entity extraction aliases.
Pembrolizumab in Neoplasms or Lymphomas
- Status
- SUSPENDED
- Phase
- PHASE2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- Status
- RECRUITING
- Phase
- PHASE2
Study of Neoadjuvant Treatment of Locally Advanced Breast Cancer With CAP Regimen
- Status
- COMPLETED
- Phase
- PHASE2
Ribociclib + PDR001 in Breast Cancer and Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE1
FOcus on Reducing Dose-limiting Toxicities in Colon Cancer With Resistance Exercise Study
- Status
- COMPLETED
- Phase
- NA
A Nurse Led Project to Introduce Hand Lettering as a Form of Creative Art Expression to Patients in an Ambulatory Oncology Setting
- Status
- COMPLETED
- Phase
- NA
Storytelling Narrative Communication Intervention for Smoking Cessation in Women Living With HIV
- Status
- COMPLETED
- Phase
- PHASE1
Neratinib +/- Fulvestrant in HER2+, ER+ Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Web-based Insomnia Treatment for Adolescent and Young Adult Cancer Survivors
- Status
- COMPLETED
- Phase
- NA
Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Optimizing Brachytherapy Application and Delivery With MRI Guidance for Gynecologic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Electronic Patient Reporting of Symptoms During Cancer Treatment
- Status
- COMPLETED
- Phase
- NA
Nivolumab Plus Ipilimumab in Thyroid Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Shared Care: Patient-Centered Management After Hematopoietic Cell Transplantation
- Status
- COMPLETED
- Phase
- NA
Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Post-Operative Ambulatory Challenge and Exercise (PACE) Trial
- Status
- COMPLETED
- Phase
- NA
An Exploratory Study to Evaluate the Combination of Elotuzumab and Nivolumab With and Without Pomalidomide in Relapsed Refractory Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of Ulocuplumab And Ibrutinib in Symptomatic Patients With Mutated CXCR4 Waldenstrom's Macroglobulinemia
- Status
- TERMINATED
- Phase
- PHASE1